Scientific publications

Environment International, 2020

Plasma perfluoroalkyls are associated with decreased levels of proteomic inflammatory markers in a cross-sectional study of an elderly population

Salihovic S., Lind L., Larsson A. et al.

Nature Genetics, 2020

Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases

Zheng J., Haberland V., Baird D. et al.

Proteomes, 2020

Profiling of Inflammatory Proteins in Plasma of HIV-1-Infected Children Receiving Antiretroviral Therapy

Lemma M., Petkov S., Bekele Y. et al.

Cell, 2020

The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19

Consiglio C., Cotugno N., Sardh F. et al.

The Journal of Clinical Endocrinology & Metabolism, 2020

Biomarkers of Inflammation and Glomerular Filtration Rate in Individuals with Recent-Onset Type 1 and Type 2 Diabetes

Maalmi H., Herder C., Strassburger K. et al.

Translational Vision Science & Technology, 2020

Comparative Analysis of Multiplex Platforms for Detecting Vitreous Biomarkers in Diabetic Retinopathy

Lamy R., Farber-Katz S., Vives F. et al.

Rheumatology, 2020

Interferon activation status underlies higher antibody response to viral antigens in patients with systemic lupus erythematosus receiving no or light treatment

Björk A., Da Silva Rodrigues R., Richardsdotter Andersson E. et al.

Circulation, 2020

Colchicine Attenuates Inflammation Beyond the Inflammasome in Chronic Coronary Artery Disease

Opstal T., Hoogeveen R., Fiolet A. et al.

Frontiers in Public Health, 2020

Exposure to Mild Steel Welding and Changes in Serum Proteins With Putative Neurological Function—A Longitudinal Study

Gliga A., Taj T., Wahlberg K. et al.

Nature Reviews Genetics, 2020

Genetics meets proteomics: perspectives for large population-based studies

Suhre K., McCarthy M., Schwenk J.

Cancers, 2020

Preoperative Fasting and General Anaesthesia Alter the Plasma Proteome

Gyllensten U., Bosdotter Enroth S., Stålberg K. et al.

Critical Care Explorations, 2020

Novel Outcome Biomarkers Identified With Targeted Proteomic Analyses of Plasma From Critically Ill Coronavirus Disease 2019 Patients

Fraser D., Cepinskas G., Patterson E. et al.

Nature Medicine, 2020

An inflammatory cytokine signature predicts COVID-19 severity and survival

Del Valle D., Kim-Schulze S., Huang H. et al.

Environmental Research, 2020

Association between prenatal immune phenotyping and cord blood leukocyte telomere length in the PRISM pregnancy cohort

Colicino E., Cowell W., Bozack A. et al.

Science Immunology, 2020

Natural killer cell immunotypes related to COVID-19 disease severity

Maucourant C., Filipovic I., Ponzetta A. et al.

Proceedings of the National Academy of Sciences, 2020

Multiomic blood correlates of genetic risk identify presymptomatic disease alterations

Wainberg M., Magis A., Earls J. et al.

Clinical Cancer Research, 2020

Integration of Antiangiogenic Therapy with Cisplatin and Gemcitabine Chemotherapy in Patients with Nasopharyngeal Carcinoma

Chong W., Lim C., Sinha A. et al.

Frontiers in Immunology, 2020

Tape-Strip Proteomic Profiling of Atopic Dermatitis on Dupilumab Identifies Minimally Invasive Biomarkers

He H., Olesen C., Pavel A. et al.

Clinical Research in Cardiology, 2020

Multi-proteomic approach to predict specific cardiovascular events in patients with diabetes and myocardial infarction: findings from the EXAMINE trial

Ferreira J., Sharma A., Mehta C. et al.

European Heart Journal, 2020

Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation

Wallentin L., Lindbäck J., Eriksson N. et al.